SCHEMBL24258312

SCHEMBL24258312

CNC(C)c1ccc2cc(OC)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.60
ABCB11 O95342 1/20 0.57
AKR1C3 P42330 6/20 0.56
AKR1C2 P52895 6/20 0.56
PTGS2 P35354 3/20 0.56
PTGS1 P23219 3/20 0.56
TSHR P16473 2/20 0.56
CYP1A2 P05177 2/20 0.56
CDC42 P60953 1/20 0.56
RAC1 P63000 1/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
CYP2D6 P10635 1/20 0.54
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C9 P11712 1/20 0.53
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CYP2A6 P11509 1/20 0.48
AKR1C1 Q04828 1/20 0.47
PDE2A O00408 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9443943 0.84 ALOX5 (0.68) ALOX5ABCB11AKR1C3AKR1C2PTGS2
SCHEMBL5473417 0.82 ABCB11 (0.58) ALOX5ABCB11AKR1C3AKR1C2PTGS2
SCHEMBL5473415 0.82 ABCB11 (0.58) ALOX5ABCB11AKR1C3AKR1C2PTGS2
SCHEMBL13462356 0.82 CA1 (0.56) TSHRCYP2D6MAPTTDP1L3MBTL1
SCHEMBL327954 0.82 CA1 (0.56) TSHRCYP2D6MAPTTDP1L3MBTL1
SCHEMBL8239398 0.82 CA1 (0.56) TSHRCYP2D6MAPTTDP1L3MBTL1
Hydrochloric Acid SCHEMBL3654829 0.80 CA1 (0.55) TSHRCYP2D6LMNAMAPTTDP1
SCHEMBL20398797 0.80 ABCB11 (0.65) ALOX5ABCB11AKR1C3AKR1C2PTGS2
SCHEMBL487168 0.80 ABCB11 (0.65) ALOX5ABCB11AKR1C3AKR1C2PTGS2
SCHEMBL29365195 0.80 ABCB11 (0.65) ALOX5ABCB11AKR1C3AKR1C2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed